Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 15, 2017 08:00 ET | Source: Interleukin Genetics, Inc.

Interleukin Genetics and Pittsburgh Business Group on Health Forge Relationship to Bring the ILUSTRA™ Inflammation Management Program to Pittsburgh Area Employers

WALTHAM, Mass., Feb. 15, 2017 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life sciences company focused on the genetics of chronic inflammation, announced today that it has...
November 15, 2016 08:00 ET | Source: Interleukin Genetics, Inc.

Interleukin Genetics Reports Third Quarter 2016 Financial Results

WALTHAM, Mass., Nov. 15, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU) today announced financial results for its fiscal third quarter of 2016, ended September 30, 2016, and...
November 09, 2016 08:00 ET | Source: Interleukin Genetics, Inc.

Interleukin Genetics Announces Conference Call to Discuss Third Quarter 2016 Financial Results

WALTHAM, Mass., Nov. 09, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU) announced today that it will host a conference call and webcast on Tuesday, November 15, 2016, at 8:30 a.m....
November 03, 2016 08:00 ET | Source: Interleukin Genetics, Inc.

Interleukin Genetics Launches The ILUSTRA™ Inflammation Management Program

WALTHAM, Mass., Nov. 03, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU) a life science company focused on the genetics of chronic inflammation, today unveiled the ILUSTRA™...
September 22, 2016 08:00 ET | Source: Interleukin Genetics, Inc.

Interleukin Genetics Cites Role in Key Antisense Drug Trial Published in The Lancet

WALTHAM, Mass., Sept. 22, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life science company focused on the genetics of chronic inflammation, today announced their contribution...
August 23, 2016 08:00 ET | Source: Interleukin Genetics, Inc.

Interleukin-1 Genetic Variations Influence Obesity Effect in Periodontal Disease Progression

WALTHAM, Mass., Aug. 23, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU) a life science company focused on the genetics of chronic inflammation, today announced the publication of...
August 16, 2016 08:00 ET | Source: Interleukin Genetics, Inc.

Interleukin Genetics Reports Second Quarter 2016 Financial Results

WALTHAM, Mass., Aug. 16, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU) today announced financial results for its fiscal second quarter of 2016, ended June 30, 2016, and provided a...
August 09, 2016 08:00 ET | Source: Interleukin Genetics, Inc.

Interleukin Genetics Announces Conference Call to Discuss Second Quarter 2016 Financial Results

WALTHAM, Mass., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU) announced today that it will host a conference call and webcast on Tuesday, August 16, 2016, at 8:30 a.m....
August 03, 2016 08:00 ET | Source: Interleukin Genetics, Inc.

Interleukin Genetics Strengthens Commercial Leadership with Key Appointments

WALTHAM, Mass., Aug. 03, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life science company focused on the genetics of chronic inflammation, today announced the appointment of...
August 01, 2016 08:00 ET | Source: Interleukin Genetics, Inc.

Interleukin Genetics, Inc. Announces $5.6 Million Private Placement Financing

WALTHAM, Mass., Aug. 01, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life sciences company focused on developing and marketing proprietary genetic tests for chronic diseases...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right